[Topical treatment of dermatoses with difluocortolone valerate fatty ointment].
The aim of the study was to compare the therapeutic effect of the new corticoid, diflucortolone valerate, with the effect of fluocinolone acetonide. The study was conducted as a randomised double-blind trial in 60 patients with various dermatoses. The results were good in 89% of the cases treated with diflucortolone valerate fatty ointment, while the same result was achieved in only 63.5% of the cases treated with fluocinolone acetonide ointment. No side effects were observed during the use of diflucortolone valerate fatty ointment, while local side effects occurred in 2 cases during the use of fluocinolone acetonide ointment.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003872:Dermatitis / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000627:therapeutic use*; D005448:Fluocortolone / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D009824:Ointments; D011244:Pregnadienediols / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*; D014631:Valerates / Q000627:therapeutic use
D009824:Ointments; D011244:Pregnadienediols; D014631:Valerates; D005446:Fluocinolone Acetonide; D005448:Fluocortolone
Topische Behandlung von Dermatosen mit Diflucortolonvalerianat in Fettsalbenform